It rarely arrives as a single moment. For many women, interest in intimacy drifts away so gradually that you only notice once the distance has settled in — and then comes the quiet guilt of not feeling like yourself. Before anyone talks about "support," a thoughtful provider does something less dramatic and more useful: they look at the whole picture, including your labs.

This article is educational and is not medical advice. It walks through the biomarkers an independent provider may consider when a woman in her forties or fifties notices a faded libido — and why the goal is to separate fixable physiology from the ordinary weight of a stressful life.

Desire is a system, not a switch

Low desire in midlife is almost never one thing. Sexual interest in women is influenced by hormones, sleep, mood, medications (including some antidepressants and hormonal contraceptives), relationship context, and overall health. The clinical term for distressing low desire is hypoactive sexual desire disorder, and major reviews emphasize that it is *multifactorial* — biology and psychology braided together [1].

That matters for two reasons. First, it means your experience is real and worth investigating, not a character flaw. Second, it means a single lab value will rarely "explain" everything. Labs are one input a provider uses to understand what's adjustable — not a verdict on you.

Why desire is treated as multifactorial
Bio + PsychDomains a provider considershormones, mood, meds, relationship
HSDDClinical framingdistressing low desire is a recognized condition
RareSingle 'cause'usually several contributors overlap

Source: [1] Hypoactive Sexual Desire Disorder in Women (StatPearls/NCBI Bookshelf)

The hormone markers a provider may review

Estradiol and the menopause transition

The years before and around the final menstrual period — perimenopause and menopause — bring large, sometimes erratic shifts in estradiol, the main estrogen. Declining estradiol is associated with vaginal dryness and tissue changes (the genitourinary syndrome of menopause) that can make intimacy uncomfortable, which in turn can dampen desire [2]. A provider often pairs estradiol with FSH (follicle-stimulating hormone) to understand where you are in the transition, while recognizing that hormone levels can swing day to day in perimenopause [2][3].

Testosterone and SHBG

Women make and use testosterone too, and it is frequently discussed in the context of desire. Here the science is careful: a 2019 global position statement from multiple endocrine and menopause societies concluded that blood testosterone levels do *not* reliably predict sexual function, so testosterone is not used as a diagnostic test for low desire [4]. What a provider may still review is total testosterone alongside SHBG (sex hormone–binding globulin), which binds testosterone and influences how much is free — mostly to build context and rule out other issues, not to confirm a diagnosis [4].

DHEA and DHEA-S

DHEA and its sulfate form DHEA-S are adrenal hormones that serve as upstream building blocks for both estrogens and androgens, and they decline steadily with age [5]. Because of that biology, DHEA-S sometimes appears on a midlife panel to round out the adrenal-hormone picture. Evidence on DHEA supplementation for sexual function in healthy women remains limited and mixed, so it is information a provider interprets in context — not a number that dictates a plan [5].

Don't skip the thyroid (and a few quiet culprits)

Thyroid disease is common in women, often develops in midlife, and can blunt energy, mood, and libido — symptoms easy to attribute to "just stress." A provider typically checks TSH as the first-line screen, sometimes with free T4, because hypothyroidism is both common and treatable [6]. Estimates suggest hypothyroidism affects a meaningful share of women, and the prevalence rises with age [6].

Other routine markers help separate physiology from fatigue: a complete blood count to check for anemia, ferritin for iron stores, and a metabolic panel. Sleep, alcohol, certain medications, mood, and the relationship itself all sit in the same frame. The point of the panel is not to find a single broken part — it's to make sure nothing fixable is being missed before a conversation about options.

TSH: a common first-line thyroid screen
Typical reference range 4Provider reviews further 10

mIU/L (lab ranges vary) · marker = Common upper reference

Source: [6] Hypothyroidism (Underactive Thyroid) — NIDDK / NIH

What the numbers can and can't tell you

It helps to hold labs loosely. A normal hormone panel does not mean your concern isn't real; an abnormal thyroid result doesn't guarantee it explains everything. Because desire is multifactorial, the most useful outcome of testing is often a *shorter list* — confirming, for example, that thyroid and iron are fine, so the conversation can shift toward menopause-related tissue changes, sleep, mood, or relationship context [1][4].

This is also why a brief, private conversation with a provider matters as much as the bloodwork. You won't have to perform or justify anything. A good intake treats low desire the way it treats any other health concern: with questions, context, and respect.

A typical review sequence (illustrative, not a protocol)
1Private intakehistory, meds, symptoms, context
2Labs as contextthyroid, estradiol/FSH, iron, CBC
3Interpret togetherseparate fixable physiology from stress
4Discuss optionsprovider-decided, never guaranteed

Source: [1] Hypoactive Sexual Desire Disorder in Women (StatPearls/NCBI Bookshelf), [4] Global Consensus Position Statement on the Use of Testosterone Therapy for Women (2019), [6] Hypothyroidism (Underactive Thyroid) — NIDDK / NIH

A note on hormone options and compounded products

There are legitimate, evidence-informed paths a provider may discuss with women — and they are decided individually, never guaranteed. Any decision about menopausal hormone therapy or other support belongs to an independent licensed provider who knows your history, including risks and your personal preferences [2][4]. No specific medication is right for everyone, and a prescription is never promised.

If compounded medications ever come up in your care, know this clearly: Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.

Where Velri fits

Velri is a technology and coordination company — not a medical practice. We help organize the unglamorous logistics: arranging lab work, connecting you with an independent, licensed provider who can review your markers and your story in a private visit, and — *only if that provider prescribes* — coordinating with an independent licensed pharmacy. The medical decisions are theirs and yours, made together. Velri's role is to make the path calmer and clearer, so the focus stays where it belongs: understanding your body and feeling like yourself again, on your own terms.

*This article is educational and not medical advice. Talk with a licensed provider about your individual situation.*